Skip to main content
Shaun Jackson, MD, Pediatric Nephrology, Seattle, WA

ShaunWilliamJacksonMD

Pediatric Nephrology Seattle, WA

Pediatric Glomerular Disease Nephrology

Associate Professor, Pediatrics, University of Washington School of Medicine

Dr. Jackson is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Jackson's full profile

Already have an account?

  • Office

    4800 Sand Point Way NE
    # Seattle
    Seattle, WA 98105
    Phone+1 857-891-6790

Education & Training

  • University of Washington
    University of WashingtonFellowship, Pediatric Rheumatology, 2009 - 2012
  • University of Washington
    University of WashingtonFellowship, Pediatric Nephrology, 2008 - 2009
  • Boston Children’s Hospital/Boston Medical Center
    Boston Children’s Hospital/Boston Medical CenterResidency, Pediatrics, 2005 - 2008
  • University of Cape Town Faculty of Medicine
    University of Cape Town Faculty of MedicineClass of 2001

Certifications & Licensure

  • WA State Medical License
    WA State Medical License 2008 - 2025
  • American Board of Pediatrics Pediatric Nephrology
  • American Board of Pediatrics Pediatric Rheumatology

Awards, Honors, & Recognition

  • Postdoctoral fellow poster prize University of Washington, 2013
  • Arnold Lee Smith Endowed Professorship for Research Faculty Development 2013
  • Outstanding Presentation Award Seattle Children’s Fellow and Resident Research Day, 2012
  • Join now to see all

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Integrated B Cell, Toll-like, and BAFF Receptor Signals Promote Autoantibody Production by Transitional B Cells  
    David J Rawlings, Shaun W Jackson, The Journal of Immunology
  • B cells take the front seat: Dysregulated B cell signals orchestrate loss of tolerance and autoantibody production  
    Jackson SW, Kolhatkar N, Rawlings DJ, Current Opinion in Immunology, 1/10/2015
  • Opposing impact of B cell intrinsic TLR7 and TLR9 signals on autoantibody repertoire and systemic inflammation  
    Jackson SW, Scharping NE, Kolhatkar N, Khim S, Schwartz MA, Li QZ, Hudkins KL, Alpers CE, Liggitt D, Rawlings DJ, J Immunol, 1/1/2014
  • Join now to see all

Books/Book Chapters

  • Join now to see all

Abstracts/Posters

  • Opposing impact of B cell intrinsic TLR7 and TLR9 signals on autoantibody repertoire and systemic inflammation
    Jackson SW, Scharping NE, Kolhatkar N, Khim S, Schwartz MA, Li QZ, Hudkins KL, Alpers CE, Liggitt D, Rawlings DJ, Pediatric Academic Societies (PAS), 1/1/2014
  • B Cell-Intrinsic Deletion of the Type 1 Interferon Receptor Does Not Impact the Development of Murine Lupus
    Jackson SW, Jacobs H, Scharping NE, Khim S, Rawlings DJ, American College of Rheumatology (ACR) annual meeting, 1/1/2014
  • Trypanosoma cruzi trans-sialidase initiates an ROR-gt independent program leading to high-level IL-17 production by activated B cells
    Bermejo DA, Jackson SW, Gorosito-Serran M, Acosta-Rodriguez EV, Amezcua-Vesely MC, Sather BD, Singh AK, Khim S, Liggitt D, Mucci J, Campetella O, Oukka M, Gruppi A, R..., Keystone Symposium, “B Cell Development and Function”, 1/1/2013
  • Join now to see all

Press Mentions

  • Updates in Pediatric Lupus: Experts Discuss Advances in Lupus Nephritis Treatments, Monogenic Lupus & More
    Updates in Pediatric Lupus: Experts Discuss Advances in Lupus Nephritis Treatments, Monogenic Lupus & MoreAugust 31st, 2021
  • Lupus Research Alliance Awards $3 Million to Advance Pediatric Lupus Nephritis Diagnosis and Treatment
    Lupus Research Alliance Awards $3 Million to Advance Pediatric Lupus Nephritis Diagnosis and TreatmentAugust 3rd, 2023
  • Seattle Children’s Set to Launch First U.S. CAR T-cell Clinical Trial for Children with Lupus
    Seattle Children’s Set to Launch First U.S. CAR T-cell Clinical Trial for Children with LupusMarch 19th, 2024
  • Join now to see all